Generally, ANRIL is a prognostic biomarker and an oncomiR in human cancers, such as lung cancer, gastric cancer, and esophageal squamous cell carcinoma [17]. The gene discussed is CDKN2B-AS1; the disease is esophageal squamous cell carcinoma.